(Reuters) - Danish pharma company Alk Abello said on Monday it would invest about 1 billion Danish crowns ($159.5 million) over the next three years to develop its North America business and said it expected earnings to be subdued during this period....
Original Article: Danish pharma company Alk Abello to invest 1 billion crowns in North America
NEXT ARTICLE